Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations.
BACKGROUND
T- and B-cell depletion of apheresis products is an attractive alternative to standard stem cell enrichment in haplo-identical transplantation. Thorough T- and B-cell depletion is necessary for prevention of acute GvHD and T-cell depletion-associated lymphoproliferative disorders. However, the large number of non-T and -B cells in the graft requires special protocols for the determination of extremely low frequencies of residual T cells.


METHODS
Apheresis products from healthy donors were T- and B-cell depleted by the CliniMACS system using CD3 and CD19 Ab reagents and the LS tubing set. The recovery of cells and degree of depletion were determined. A four-color multigating strategy was used for enumeration of residual T and B cells.


RESULTS
One-hundred and three separations were performed, with a mean cell recovery of 38+/-12%, CD34 recovery of 61+/-16% and CD56 recovery of 63+/-33%. T and B cells were depleted by log 4.15+/-0.46 and log 3.64+/-0.63, respectively. Four-color multigating flow cytometry allowed the detection of single T cells.


CONCLUSIONS
Combined T- and B-cell depletion is a feasible method for obtaining stem cell grafts with acceptable stem cell recovery, profound T- and B-cell depletion and a very high amount of NK cells and monocytes. However, analysis of residual T cells is challenging and requires special protocols.
Schumm
M
M
Children's University Hospital Tübingen, Tübingen, Germany. michael.schumm@med.uni-tuebingen.de
Handgretinger
R
R
Pfeiffer
M
M
Feuchtinger
T
T
Kuci
S
S
Faul
C
C
Vogel
W
W
Bethge
W
W
Lang
P
P
D000208:Acute Disease; D001402:B-Lymphocytes / Q000166:cytology; D005434:Flow Cytometry / Q000379:methods; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D018189:Immunomagnetic Separation / Q000379:methods; D007937:Leukapheresis / Q000379:methods; D008212:Lymphocyte Depletion / Q000379:methods; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D013601:T-Lymphocytes / Q000166:cytology; D014184:Transplantation, Homologous